Is Ginkgo Bioworks Stock a Good Buy?
Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…
Buy
65
UVSP Quote, Financials, Valuation and Earnings
Last price:
$30.63
Seasonality move
:
0.45%
Day range:
$30.25 - $30.89
52-week range:
$20.37 - $32.75
Dividend yield:
2.76%
P/E ratio:
11.52x
P/S ratio:
2.99x
P/B ratio:
0.98x
Volume:
190.3K
Avg. volume:
131.3K
1-year change:
34.19%
Market cap:
$888.6M
Revenue:
$299.2M
EPS (TTM):
$2.67
Analysts' Opinion
-
Consensus RatingUnivest Financial has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $31.67, Univest Financial has an estimated upside of 2.91% from its current price of $30.77.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $31.00 representing 100% downside risk from its current price of $30.77.
Fair Value
-
According to the consensus of 3 analysts, Univest Financial has 2.91% upside to fair value with a price target of $31.67 per share.
UVSP vs. S&P 500
-
Over the past 5 trading days, Univest Financial has underperformed the S&P 500 by -2.08% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Univest Financial does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Univest Financial has grown year-over-year revenues for 3 quarters straight. In the most recent quarter Univest Financial reported revenues of $79.2M.
Earnings Growth
-
Univest Financial has grown year-over-year earnings for 4 quarters straight. In the most recent quarter Univest Financial reported earnings per share of $0.77.
Enterprise value:
1B
EV / Invested capital:
0.84x
Price / LTM sales:
2.99x
EV / EBIT:
3.48x
EV / Revenue:
3.44x
PEG ratio (5yr expected):
0.98x
EV / Free cash flow:
13.79x
Price / Operating cash flow:
12.01x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
0.98%
Net Income Margin (TTM):
25.89%
Return On Equity:
8.94%
Return On Invested Capital:
6.26%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $308M | $294.9M | $301.4M | $77.1M | $79.2M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $2.68 | $2.39 | $2.67 | $0.69 | $0.77 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $587.8M | $1.3B | $727M | $799.4M | $410M | |
| Total Assets | $6.4B | $7.1B | $7.4B | $7.7B | $8B | |
| Current Liabilities | $26.7M | $19M | $271.9M | $4.8M | $4M | |
| Total Liabilities | $5.7B | $6.3B | $6.6B | $6.9B | $7.1B | |
| Total Equity | $722.5M | $773.9M | $798.5M | $843.7M | $903.5M | |
| Total Debt | $268.6M | $194M | $368.4M | $398.9M | $324.4M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $106.3M | $80.6M | $79.1M | $11.6M | $15.6M | |
| Cash From Investing | -$920.2M | -$320.1M | -$248.4M | -$14.5M | -$3.1M | |
| Cash From Financing | $178.5M | $302.8M | $136.7M | -$45.3M | -$172.2M | |
| Free Cash Flow | $99.1M | $75.4M | $75.1M | $10.5M | $13.7M | |
UVSP
Sector
Market Cap
$888.6M
$628.1M
Price % of 52-Week High
93.95%
87.3%
Dividend Yield
2.76%
1.97%
Shareholder Yield
8.46%
4.02%
1-Year Price Total Return
34.19%
9.14%
Beta (5-Year)
0.728
0.587
Dividend yield:
2.76%
Annualized payout:
$0.84
Payout ratio:
32.09%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$30.81
200-day SMA
Buy
Level
$28.97
Bollinger Bands (100)
Buy
Level
27.88 - 30.74
Chaikin Money Flow
Buy
Level
12.3M
20-day SMA
Buy
Level
$30.05
Relative Strength Index (RSI14)
Buy
Level
59.68
ADX Line
Buy
Level
17.15
Williams %R
Neutral
Level
-31.761
50-day SMA
Buy
Level
$28.65
MACD (12, 26)
Buy
Level
0.72
25-day Aroon Oscillator
Buy
Level
76
On Balance Volume
Neutral
Level
7M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.4019)
Sell
CA Score
(Annual)
Level (-2.0805)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (1.9943)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Univest Financial Corp is engaged in domestic banking services for individuals, businesses, municipalities and non-profit organizations. The bank has three operating segments; Banking segment provides financial services including a full range of banking services such as deposit taking, loan origination, and servicing, mortgage banking, other general banking services, and equipment lease financing, Wealth Management segment offers investment advisory, financial planning, trust and brokerage services, and The Insurance segment includes a full-service insurance brokerage agency offering commercial property and casualty insurance, employee benefits solutions, personal insurance lines and human resources consulting. It generates majority of its revenue from the banking segment.
Stock Forecast FAQ
In the current month, UVSP has received 0 Buy ratings 3 Hold ratings, and 0 Sell ratings. The UVSP average analyst price target in the past 3 months is $31.67.
-
Where Will Univest Financial Stock Be In 1 Year?
According to analysts, the consensus estimate is that Univest Financial share price will rise to $31.67 per share over the next 12 months.
-
What Do Analysts Say About Univest Financial?
Analysts are divided on their view about Univest Financial share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Univest Financial is a Sell and believe this share price will drop from its current level to $31.00.
-
What Is Univest Financial's Price Target?
The price target for Univest Financial over the next 1-year time period is forecast to be $31.67 according to 3 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is UVSP A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Univest Financial is a Hold. 3 of 3 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of UVSP?
You can purchase shares of Univest Financial via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Univest Financial shares.
-
What Is The Univest Financial Share Price Today?
Univest Financial was last trading at $30.63 per share. This represents the most recent stock quote for Univest Financial. Yesterday, Univest Financial closed at $30.77 per share.
-
How To Buy Univest Financial Stock Online?
In order to purchase Univest Financial stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Mobileye Might Be Wall Street’s Next Big Surprise
The trend to automate vehicles started long ago when adding…
Why Is Rigetti Stock Going Up?
Quantum computing firm Rigetti Computing (NASDAQ:RGTI) has been one of…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
71
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
99
SOC alert for May 20
Sable Offshore [SOC] is down 0.79% over the past day.
Buy
52
RGC alert for May 20
Regencell Bioscience Holdings [RGC] is up 31.16% over the past day.
Sell
40
GWLIF alert for May 20
Great-West Lifeco [GWLIF] is up 13.42% over the past day.
